Hualan Biological Engineering INC
Research Hualan Biological Engineering INC (002007.SZ) on Bullrun: market cap CNY 23.57B, P/E 29.3, dividend yield 7.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker002007.SZ
- ExchangeSZ
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCNY
- Market capCNY 23.57B
- P/E29.3
- Dividend yield7.8%
- Financial periodQ2 2026
- RevenueCNY 804.53M
- Net incomeCNY 153.01M
- Free cash flowCNY 321.62M
- Gross margin42.4%
Valuation Snapshot
latest market cap is CNY 23.57B; P/E is 29.3; dividend yield is 7.8%.
Peer valuation comparison
Latest P/E is 29.34x versus a Healthcare sector median of 21.75x (34.9% above).
Latest dividend yield is 7.75% versus a Healthcare sector median of 2.4% (222.9% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | CNY 23.57B | 29.3 | 7.8% | 1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1 CNY, yield 7.8%.
About Hualan Biological Engineering INC
Hualan Biological Engineering Inc., together with its subsidiaries, engages in the research, development, production, and sale of biological products in China and internationally. The company offers blood products, including human serum albumin, human prothrombin complex concentrate, human coagulation factor VIII, human fibrinogen, and freeze-dried human fibrin glue for surgical use, as well as intravenous, human, rabies, hepatitis B, and tetanus immunoglobulin for various therapeutic applications.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Hualan Biological Engineering INC's market cap?
Hualan Biological Engineering INC's market capitalization is CNY 23.57B.
What is Hualan Biological Engineering INC's P/E ratio?
Hualan Biological Engineering INC's price-to-earnings (P/E) ratio is 29.3.
Does Hualan Biological Engineering INC pay a dividend?
Hualan Biological Engineering INC has a dividend yield of 7.8%.
What does Hualan Biological Engineering INC do?
Hualan Biological Engineering Inc., together with its subsidiaries, engages in the research, development, production, and sale of biological products in China and internationally. The company offers blood products, including human serum albumin, human prothrombin complex concentrate, human coagulation factor VIII, human fibrinogen, and freeze-dried human fibrin glue for surgical use, as well as intravenous, human, rabies, hepatitis B, and tetanus immunoglobulin for various therapeutic applications.